← Russell 3000 cross-section

ELMD Electromed, Inc.

Trailing twelve months to 2026-06-30 · as filed 2026-08-25, not restated
Healthcare

Scale

Market cap
$257m
Revenue TTM
$74m
Net income TTM
$11m
Free cash flow
$8m
Composite score
69.7
Sector rank
#2757

Valuation

P / E
22.7
EV / EBITDA
16.0
EV / sales
3.2
FCF yield
3.27%
Earnings yield vs 10-yr
-0.33pp

Earnings yield vs 10-yr compares what the business earns per pound invested against the 4.73% a 10-year US Treasury note pays for no equity risk. Negative means you are paying up front for growth not yet delivered.

Quality and growth

Net margin
15.3%
EBITDA margin
20.1%
ROE
20.9%
ROIC
41.4%
Revenue growth
15.3%

Insider activity, last 90 days

Net open-market
$-0.78m
Buyers
0
Sellers
2

Open-market purchases and sales only. Grants, option exercises, gifts and shares withheld for tax are excluded: they are how people are paid, not what they think.

What management said

Homecare revenue increased by $2,630,000, or 18.6%, for the three months ended March 31, 2026, compared to the same period in the prior year. Approximately $1,959,000 of the increase in revenue was due to higher volume, which was driven by additional sales representatives and increased sales representative productivity, and approximately $671,000 was due to higher net revenues per approval. For the nine months ended March 31, 2026, homecare revenue increased by $6,989,000, or 16.7%, compared to the same period in the prior year. …Electromed, Inc., 10-Q, period ended 2026-03-31, filed 2026-05-12

Read the full passage →